Multidrug Resistant Tuberculosis (MDR-TB) Cost Effectiveness Analysis Tool

The Multidrug Resistant Tuberculosis (MDR-TB) Cost Effectiveness Analysis Tool is a simple, user-friendly, generic tool that is allows countries to compare the cost-effectiveness of different MDR-TB diagnoses and treatment methods. The tool builds on previous studies about MDR-TB control cost-effectiveness and WHO guidelines on TB control costs and cost-effectiveness. It can be used to compare the costs and effectiveness of different treatment strategies from the provider perspective. For outcome measures, the tool uses case completion rate, cure rate, and cost of deaths averted. The intended users are district, provincial, and central level TB program managers and planners.

If you have questions regarding this tool or would like assistance using it and the associated Excel workbook, please contact: fintools@msh.org